Evaluation of hepatocellular carcinoma using contrast-enhanced ultrasonography: Correlation with microvessel morphology

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 6, 2010, Pages 605-610

  Xiao, Ji Dong ^a   Zhu, Wen Hui ^a   Shen, Shou Rong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Contrast enhanced ultrasonography; Hepatocellular carcinoma; Microvessel morphology

Indexed keywords

MONOCLONAL ANTIBODY;

ARTICLE; CANCER MORPHOLOGY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MICROVASCULATURE; PORTAL VEIN; QUANTITATIVE ANALYSIS; TISSUE SECTION; TUMOR VASCULARIZATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CONTRAST MEDIA; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; ULTRASONOGRAPHY;

EID: 78650206693     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. El-Assal ON, Yamanoi A, Soda Y, Yamaguchi M, Igarashi M, Yamamoto A, et al. Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver. Hepatology 1998;27:1554-1562.
2. Zhu AX, Holalkere NS, Muzikansky A, Horgan K, Sahani DV. Early antiangiogenic activity of bevacizumab evaluated by computed tomography perfusion scan in patients with advanced hepatocellular carcinoma. Oncologist 2008;13:120-125.
3. Romanque P, Piguet AC, Dufour JF. Targeting vessels to treat hepatocellular carcinoma. Clin Sci (Lond) 2008;114:467-477.
4. Mueller-Lisse UG, Mueller-Lisse UL. Imaging of advanced renal cell carcinoma. World J Urol 2010;28:253-261.
5. Zhao L, Zhan Y, Rutkowski JL, Feuerstein GZ, Wang X. Correlation between 2- and 3-dimensional assessment of tumor volume and vascular density by ultrasonography in a transgenic mouse model of mammary carcinoma. J Ultrasound Med 2010;29:587-595.
6. Forsberg F. Can the effect of antiangiogenic treatments be monitored and quantified noninvasively by using contrastenhanced US? Radiology 2010;254:317-318.
7. Zee YK, O'Connor JP, Parker GJ, Jackson A, Clamp AR, Taylor MB, et al. Imaging angiogenesis of genitourinary tumors. Nat Rev Urol 2010;7:69-82.
8. Shiyan L, Pintong H, Zongmin W, Fuguang H, Zhiqiang Z, Yan Y, et al. The relationship between enhanced intensity and microvessel density of gastric carcinoma using double contrast-enhanced ultrasonography. Ultrasound Med Biol 2009;35:1086-1091.
9. Claudon M, Cosgrove D, Albrecht T, Bolondi L, Bosio M, Calliada F, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)- update 2008. Ultraschall Med 2008;29:28-44.
10. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
11. Klauser A, Demharter J, De Marchi A, Sureda D, Barile A, Masciocchi C, et al. Contrast enhanced gray-scale sonography in assessment of joint vascularity in rheumatoid arthritis: Results from the IACUS study group. Eur Radiol 2005;15:2404-2410.
12. Sugimoto K, Moriyasu F, Kamiyama N, Yamada M, Iijima H. Correlation between parametric imaging using contrast ultrasound and the histological differentiation of hepatocellular carcinoma. Hepatol Res 2008;38:273-280.
13. Nakamura S, Muro H, Suzuki S, Sakaguchi T, Konno H, Baba S, et al. Immunohistochemical studies on endothelial cell phenotype in hepatocellular carcinoma. Hepatology 1997;26: 407-415.
14. Yamamoto T, Kaneda K, Hirohashi K, Kinoshita H, Sakurai M. Sinusoidal capillarization and arterial blood supply continuously proceed with the advance of the stages of hepatocarcinogenesis in the rat. Jpn J Cancer Res 1996;87:442-450.
15. Ikebe T, Yamamoto T, Kubo S, Hirohashi K, Kinoshita H, Kaneda K, et al. Suppressive effect of the angiogenesis inhibitor TNP-470 on the development of carcinogeninduced hepatic nodules in rats. Jpn J Cancer Res 1998;89:143-149.
16. Yi CA, Lee KS, Kim EA, Han J, Kim H, Kwon OJ, et al. Solitary pulmonary nodules: Dynamic enhanced multidetector row CT study and comparison with vascular endothelial growth factor and microvessel density. Radiology 2004;233:191-199.
17. Wang JH, Min PQ, Wang PJ, Cheng WX, Zhang XH, Wang Y, et al. Dynamic CT Evaluation of Tumor Vascularity in Renal Cell Carcinoma. AJR Am J Roentgenol 2006;186:1423-1430.
18. Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, et al. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma. Hepatology 2008;47:97-104.
19. Jinzaki M, Tanimoto A, Mukai M, Ikeda E, Kobayashi S, Yuasa Y, et al. Double-phase helical CT of small renal parenchymal neoplasms: Correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr 2000;24: 835-842.
20. Rychak JJ, Graba J, Cheung AM, Mystry BS, Lindner JR, Kerbel RS, et al. Microultrasound molecular imaging of vascular endothelial growth factor receptor 2 in a mouse model of tumor angiogenesis. Mol Imaging 2007;6:289-296.
21. Lassau N, Roche A. Imaging and angiogenesis: DCE-US (dynamic contrast enhanced-ultrasonography). Bull Cancer 2007;94:S247-253.
22. Yao DF, Wu XH, Zhu Y, Shi GS, Dong ZZ, Yao DB, et al. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2005;4:220-226.
23. Wang Z, Tang J, An L, Wang W, Luo Y, Li J, et al. Contrastenhanced ultrasonography for assessment of tumor vascularity in hepatocellular carcinoma. J Ultrasound Med 2007;26:757-762.
24. Hattori Y, Gabata T, Matsui O, Mochizuki K, Kitagawa H, Kayahara M, et al. Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: Correlation with angiogenesis and fibrosis. World J Gastroenterol 2009;15:3114-3121.